Three mainboard and two SME-tier listings are scheduled across Indian exchanges in the coming fortnight, raising a combined Rs. 811 crore minimum across industrial electronics, green technology, nutrition supplements, and gold retail. Merritronix opens June 1 with a Rs. 70 crore raise; CMR Green Technologies follows with Rs. 631 crore the same week. SME jewelers Yaashvi and SMR target Rs. 43 crore and Rs. 67 crore respectively, while Hexagon Nutrition rounds the calendar with a mid-tier health supplement play. The cluster marks the heaviest two-week IPO schedule in India's non-metro segments since March.

Merritronix, a Karnataka-based industrial electronics manufacturer, anchors the wave with a June 1 subscription window targeting institutional and HNI allocators in Tier-II manufacturing hubs. CMR Green Technologies, positioning as a renewable energy component supplier, underwrites the largest single raise at Rs. 631 crore—a mainboard listing aimed at ESG-tilted domestic mutual funds and family offices rotating out of overheated large-cap tech. Hexagon Nutrition, already publicly listed on BSE, is reopening a book-building process to expand capacity in nutraceutical contract manufacturing, a segment that saw 18% CAGR in India over the past three years. Yaashvi Jewellers and SMR Jewels, both SME Exchange candidates, are raising capital for retail expansion in Gujarat and Maharashtra, respectively, where wedding-season gold demand remains structurally elevated despite global spot weakness.

The timing reflects two observable shifts in Indian domestic capital flows. First, family offices and mid-tier funds are underweighting large-cap IT and overweighting industrials and consumer discretionary with pricing power—jewellery retail qualifies as both. Second, green technology and renewable supply-chain plays are drawing pre-placement interest at valuations 30-40% below comparable Chinese manufacturers, making CMR Green's Rs. 631 crore raise the bellwether for how much foreign institutional money will cross into Indian industrials at this stage of the rate cycle. Hexagon Nutrition's re-entry also signals that contract manufacturers serving Western supplement brands are finding cheaper rupee-denominated equity more attractive than dollar debt, a reversal from 2022-2023 behavior. The jewellery SME raises, while small, are worth watching as proxies for rural purchasing power—wedding-season sales drive 60% of annual volume in this segment, and any slippage in fill rates would show up in post-IPO trading within 90 days.

Operators should track three follow-on events. First, whether CMR Green's institutional tranche fills above 2.5x oversubscription—anything below signals weak ESG appetite outside the top 10 funds. Second, the post-listing performance of Yaashvi and SMR in the first 30 days will indicate whether retail investors still trust small-cap jewellery plays after the Kalyan Jewellers post-listing fade in Q1. Third, Hexagon Nutrition's pricing relative to its previous listing will reveal how much dilution the market tolerates for capacity-expansion stories in contract manufacturing. Subscription close dates are staggered across mid-June, meaning price discovery will cascade rather than arrive in one block.

The Rs. 811 crore aggregate is less than a single mid-tier US SPAC but represents 12% of India's Q2 IPO volume if all five close as scheduled—a micro-signal that domestic liquidity is hunting yield outside Nifty 50 constituents.